A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability

Int J Mol Sci. 2024 Nov 11;25(22):12091. doi: 10.3390/ijms252212091.

Abstract

The main goal of this systematic review on the flavonol class secondary metabolite quercetin is to evaluate and summarize the existing research on quercetin's potential health benefits, therapeutic properties, and effectiveness in disease prevention and treatment. In addition to evaluating quercetin's potential for drug development with fewer side effects and lower toxicity, this type of review attempts to collect scientific evidence addressing quercetin's roles as an antioxidant, anti-inflammatory, antibacterial, and anticancer agent. In the first part, we analyze various flavonoid compounds, focusing on their chemical structure, classification, and natural sources. We highlight their most recent biological activities as reported in the literature. Among these compounds, we pay special attention to quercetin, detailing its chemical structure, physicochemical properties, and process of biosynthesis in plants. We also present natural sources of quercetin and emphasize its health benefits, such as its antioxidant and anti-inflammatory effects. Additionally, we discuss methods to enhance its bioavailability, analyzing the latest and most effective delivery systems based on quercetin.

Keywords: bioavailability; diseases; flavonoids; health benefits; quercetin; secondary metabolites.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / chemistry
  • Anti-Inflammatory Agents* / pharmacology
  • Antioxidants* / chemistry
  • Antioxidants* / pharmacology
  • Biological Availability*
  • Flavonols / chemistry
  • Flavonols / metabolism
  • Humans
  • Quercetin* / chemistry
  • Quercetin* / metabolism
  • Quercetin* / pharmacology
  • Secondary Metabolism

Substances

  • Quercetin
  • Antioxidants
  • Anti-Inflammatory Agents
  • Flavonols

Grants and funding

Support was provided by the University of Oradea through the grant competition “Scientific Research of Excellence Related to Priority Areas with Capitalization through Technology Transfer: INO TRANSFER—UO”. Project no. 258/2022.